Kaushiki Mazumdar

Antimicrobial potentiality of a new non-antibiotic: the cardiovascular drug oxyfedrine hydrochloride.

Antibacterial potential of an antispasmodic drug dicyclomine hydrochloride.

Studies on the antibacterial potentiality of isoflavones.

Amlodipine: a cardiovascular drug with powerful antimicrobial property.

Evaluation of synergism between the aminoglycoside antibiotic streptomycin and the cardiovascular agent amlodipine.

Triflupromazine: a microbicide non-antibiotic compound.

In vitro and in vivo antimycobacterial activity of antiinflammatory drug, diclofenac sodium.

Antibacterial property of the antipsychotic agent prochlorperazine, and its synergism with methdilazine.

In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains.

In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA.

Antimicrobial potentiality of the thioxanthene flupenthixol through extensive in vitro and in vivo experiments.

Pronounced inhibitory effect of chlorcyclizine (CCZ) in experimental hepatocarcinoma.

Diclofenac in the management of E. coli urinary tract infections.

Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium.

Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.

Studies on the antimicrobial potential of the cardiovascular drug lacidipine.

Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine.

TLR4-independent and PKR-dependent interleukin 1 receptor antagonist expression upon LPS stimulation.

Activity of the phenothiazine methdilazine alone or in combination with isoniazid or streptomycin against Mycobacterium tuberculosis in mice.

Noninflammatory gluten peptide analogs as biomarkers for celiac sprue.

Visualization of transepithelial passage of the immunogenic 33-residue peptide from alpha-2 gliadin in gluten-sensitive macaques.

New patentable use of an old neuroleptic compound thioridazine to combat tuberculosis: a gene regulation perspective.